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Background
Breast milk is recognized as a predominant mode of HIV-
1 infection in infants. Cell-associated HIV-1 may be the
main source of virus transmission during early phases of
breast-feeding. We have previously observed that HIV-1-
infected cells spontaneously producing virus persist in
breast-milk from women under antiretroviral therapy.
Treatment of expressed milk with a microbicide such as
Sodium dodecyl sulfate (SDS) is proposed as a simple and
safe option to inactivate both cell free and cell associated
HIV-1 when formula feeding is not practicable. However,
the effect of SDS on spontaneously HIV-1-producing
CD4+T cells in breast milk has not been fully explored.
Materials and methods
In this report human milk was spiked by HIV-1-infected
cells and treated with increasing exposure time and SDS
concentration. CD4+T cell apoptosis and death, cell-asso-
ciated HIV-1 RNA production, and spontaneous HIV-1-Ag
cell secretion were quantified after SDS treatment.
Results
Cell death increases in presence of SDS in a concentration-
and time-dependent manner, 50% of T lymphocytes
death after 2 minutes with 0.14% SDS and 90% after 10
minutes with 0.1% SDS (Fig. 1A). Undetectable HIV-1
RNA cell production was achieved following exposure
with a minimum concentration of 0.1% SDS during 2
minutes, IC50 = 0.03% (Fig. 1B). The inhibition of HIV-1
Ag secretion was explored at a single cell level by ELISpot
assay. Using this method inactivation was 100% for SDS
concentrations 0.25% within 2 min (Fig. 1C).
Conclusion
By comparison with results previously reported using an
infectivity model based on -galactosidase MAGI cells1,
we observed that a two fold higher SDS concentration was
required to complete inactivation of HIV-1-Ag-secreting
cells. This concentration remains in the reported safe lim-
its for ingestion of SDS by children (1 g/kg/day). Regard-
ing the possible occurrence of transmission to the infant
after controlling cell-free virus in breast milk from women
on antiretroviral therapy, SDS treatment of expressed
breast milk may be an interesting strategy to optimized
the prevention of HIV-1 pediatric transmission.
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Effect of SDS exposure on T cell death (A), cell-associated HIV-1 RNA production (B), and sponataeous HIV-1-Ag cell secre- tion (C) Figure 1
Effect of SDS exposure on T cell death (A), cell-associated HIV-1 RNA production (B), and sponataeous HIV-1-
Ag cell secretion (C).